Uncategorized

France’s biotech ambition is strong but its scale-up engine still needs work

France’s biotech ambition is strong but its scale-up engine still needs work

Published

on

Government backing, deep scientific talent and a robust pharma heritage are helping France punch above its weight, but turning research into investable companies remains a challenge.​ ​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version